NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nuwacell Biotechnologies Co., Ltd.

Nuwacell Biotechnologies Co., Ltd.

Private
HefeiHealthcare & Life Scienceshttps://en.nuwacell.com/

Last Round

Series A

Sep 13, 2022

Company Overview

Nuwacell Biotechnologies Co., Ltd. is a biotechnology company that develops widely accessible iPSC-derived cell therapy products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

induced pluripotent stem cellsiPSCsiPSC technologycell therapyoff-the-shelf cell therapyallogeneic cell therapyregenerative medicineiPSC cell therapycontract development and manufacturingCDMOimmunotherapyiPSC CDMOiNK cell therapyiMSC therapyiPSC cell bankculture reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuwacell Biotechnologies Co., Ltd. Comparables

Compare Nuwacell Biotechnologies Co., Ltd. with similar companies based on industry and business-model similarity.

Nuwacell Biotechnologies Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HebeCell
85%
iRegene Therapeutics
83%
iCamuno Biotherapeutics
81%

Nuwacell Biotechnologies Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 13, 2022

Nuwacell Biotechnologies Co., Ltd. Investors

Notable investors and investment history

Nuwacell Biotechnologies Co., Ltd. investors
InvestorRounds
China Merchants GroupSeries A
Legend CapitalSeries A
GF Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2022

    Led by China Merchants Group and Legend Capital

Nuwacell Biotechnologies Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nuwacell Biotechnologies Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nuwacell Biotechnologies Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHefei
Year Founded2016
Last FundingSep 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.